Wu, Y., Tang, L., Zhang, F., Yan, Z., Li, J., & Tong, N. Evaluation of the HbA1c Reduction Cut Point for a Nonglycemic Effect on Cardiovascular Benefit of Hypoglycemic Agents in Patients with Type 2 Diabetes Based on Endpoint Events. Wiley.
Chicago Style (17th ed.) CitationWu, Yuchao, Lizhi Tang, Fang Zhang, Zhe Yan, Jing Li, and Nanwei Tong. Evaluation of the HbA1c Reduction Cut Point for a Nonglycemic Effect on Cardiovascular Benefit of Hypoglycemic Agents in Patients with Type 2 Diabetes Based on Endpoint Events. Wiley.
MLA (9th ed.) CitationWu, Yuchao, et al. Evaluation of the HbA1c Reduction Cut Point for a Nonglycemic Effect on Cardiovascular Benefit of Hypoglycemic Agents in Patients with Type 2 Diabetes Based on Endpoint Events. Wiley.
Warning: These citations may not always be 100% accurate.